To investigate whether mitochondrial biogenesis affects SIRT6's resistance to cholestatic liver disease, we administered AICAR to liver-specific Sirt6 knockout mice to activate the AMPK/PGC-1α pathway, or used KNI-1 to activate NRF2. The gene discussed is PPARGC1A; the disease is Cholestatic liver disease.